Author

Scott A. Rush

The University of Texas at AustinORCID 0000-0002-9601-5068Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

Jason S. McLellaniD· 2 shared Adrian V. S. HilliD· 1 shared Ahmed Magdy KhaliliD· 1 shared Alexandra A. Abu-ShmaisiD· 1 shared Alexandra J. SpenceriD· 1 shared Alexis K. JankeiD· 1 shared C. Richter KingiD· 1 shared Duncan G. BellamyiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Jason S. McLellanORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A potently neutralizing and protective human antibody targeting antigenic site V on RSV and hMPV fusion glycoprotein

Alexandra A. Abu-Shmais, Luqiang Guo, Ahmed Magdy Khalil, Sabina E W Leonard, Rose J. Miller, Alexis K. Janke, Matthew J. Vukovich, Lindsay E Bass, Yukthi P. Suresh, Scott A. Rush, Rachael M. Wolters, Nurgun Kose, Robert H. Carnahan, James E. Crowe, Rachel H. Bonami, , Ivelin S. Georgiev

The paper identifies a human antibody that neutralizes RSV and hMPV by targeting a novel epitope spanning multiple antigenic sites, showing cross-protection in a mouse model.

Cell Reports Medicine · Jan 16, 2026Peer-reviewedImmunology

Repertoire, function, and structure of serological antibodies induced by the R21/Matrix-M malaria vaccine

Jonathan R. McDaniel, William N. Voss, Georgina Bowyer, Scott A. Rush, Alexandra J. Spencer, Duncan G. Bellamy, Marta Ulaszewska, Jule Goike, Scott Gregory, C. Richter King, Jason S. McLellan, Adrian V. S. Hill, George Georgiou, Katie Ewer, Gregory C. Ippolito

This study shows that the R21/Matrix-M malaria vaccine induces specific IgG antibodies targeting multiple CSP epitopes, contributing to its efficacy against P. falciparum malaria.

The Journal of Experimental Medicine · Jun 24, 2025Peer-reviewedImmunology